December 31, 2024 - 17:58

A recent study published in the Journal of the American College of Surgeons (JACS) reveals that mergers and acquisitions among U.S. hospitals and health systems seldom lead to improvements in the quality of care or reductions in health care costs. Despite the ongoing trend of consolidation in the healthcare sector, the anticipated benefits of these mergers often do not materialize.
The analysis indicates that while hospitals aim to enhance operational efficiency and expand their services through mergers, the expected outcomes of better patient care and lower prices are frequently unachieved. Instead, the study highlights a concerning pattern where such consolidations may contribute to increased healthcare costs without a corresponding improvement in patient outcomes.
Experts suggest that policymakers and healthcare leaders need to reconsider the implications of hospital mergers. The findings underscore the importance of focusing on strategies that genuinely enhance patient care and affordability, rather than relying on consolidation as a solution to the challenges facing the healthcare system.
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...